🇺🇸 FDA
Patent

US 10842791

Small molecule inhibitors of EGFR and PI3K

granted A61KA61K31/4706A61K31/4709

Quick answer

US patent 10842791 (Small molecule inhibitors of EGFR and PI3K) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Nov 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/4706, A61K31/4709, A61K31/517, A61K31/5377